EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

KLF1 Exerts Pro‐Tumour Role in Liver Cancer via Inhibiting ACSL4 / LPCAT3 ‐Regulated Ferroptosis

Zhihui Chen iD, Changyan Zhang, Jialin Yang, Yong Peng

Journal of Cellular and Molecular Medicine · 2026

DOI: 10.1111/jcmm.71033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2026. Verfasst von Zhihui Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Nanchong, Sichuan, C…. Hauptthemen laut MEDLINE: Kruppel-Like Transcription Factors, Liver Neoplasms, Ferroptosis, Coenzyme A Ligases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kruppel‐like factors (KLFs) constitute a crucial family of transcription factors that are engaged in a variety of biological processes, such as erythropoiesis as well as liver development. A growing body of research underscores the increasing importance of the KLF family in the context of hepatocellular carcinoma (HCC). Despite this, the exact function of KLF1 within HCC remains unclear. Our study demonstrates a significant upregulation of KLF1 expression in tumour samples from HCC patients compared to normal liver tissue, with higher expression levels strongly correlating with poorer survival outcomes. Notably, in vitro experiments have shown that KLF1 enhances liver cancer cell proliferation by inhibiting ferroptosis, and this inhibition is negatively correlated with the transcription levels of fatty acid synthase 4 (ACSL4). These findings suggest that KLF1 may exert its oncogenic potential by repressing ferroptosis through the inhibition of ACSL4 transcription. Further mechanistic investigations reveal that KLF1 inhibits ACSL4 expression via transcriptional repression and suppresses ferroptosis through the ACSL4/LPCAT3 axis, ultimately promoting HCC tumour growth as well as its advancement. In conclusion, KLF1 is essential for onset as well as development in HCC through inhibiting ACSL4 transcription along with ferroptosis, thereby presenting novel therapeutic targets for HCC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kruppel-Like Transcription FactorsLiver NeoplasmsFerroptosisCoenzyme A LigasesCarcinoma, HepatocellularHumansGene Expression Regulation, NeoplasticAnimalsCell ProliferationLong-Chain-Fatty-Acid-CoA LigaseMiceCell Line, TumorMaleFemale

Stichwörter der Autor:innen

ACSL4KLF1ferroptosisprimary hepatocellular carcinomatargeted therapy

Substanzen

Kruppel-Like Transcription FactorsCoenzyme A Ligaseserythroid Kruppel-like factorLong-Chain-Fatty-Acid-CoA Ligase

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Nanchong, Sichuan, China.

ORCID-Profile: Zhihui Chen

Zitieren

APA

Chen, Z., Zhang, C., Yang, J., & Peng, Y. (2026). KLF1 Exerts Pro‐Tumour Role in Liver Cancer via Inhibiting ACSL4 / LPCAT3 ‐Regulated Ferroptosis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.71033

Vancouver

Chen Z, Zhang C, Yang J, Peng Y. KLF1 Exerts Pro‐Tumour Role in Liver Cancer via Inhibiting ACSL4 / LPCAT3 ‐Regulated Ferroptosis. Journal of Cellular and Molecular Medicine. 2026. doi:10.1111/jcmm.71033

BibTeX
@article{Chen2026,
  author = {Chen, Zhihui and Zhang, Changyan and Yang, Jialin and Peng, Yong},
  title = {KLF1 Exerts Pro‐Tumour Role in Liver Cancer via Inhibiting ACSL4 / LPCAT3 ‐Regulated Ferroptosis},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  doi = {10.1111/jcmm.71033}
}
Kostenlos starten →